Image from Google Jackets

New treatment for opioid-induced constipation / Diane S. Aschenbrenner

By: Series: American Journal of Nursing. 115 : 1, page 23 Publication details: January 2015ISSN:
  • 0002-936X
Subject(s): Summary: An opioid antagonist, naloxegol (Movantik), has now been approved to treat opioid-induced constipation in adults with chronic noncancer pain. Naloxegol binds to mu-opiate receptors in the gastrointestinal tract, preventing opioids from attaching to them, which prevents the gastrointestinal slowing and constipation that typically occur with opioid use.
Item type: Articles
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Current library Call number Status Date due Barcode
Manila Tytana Colleges Library REFERENCE SECTION Bound (Browse shelf(Opens below)) Not For Loan

An opioid antagonist, naloxegol (Movantik), has now been approved to treat opioid-induced constipation in adults with chronic noncancer pain. Naloxegol binds to mu-opiate receptors in the gastrointestinal tract, preventing opioids from attaching to them, which prevents the gastrointestinal slowing and constipation that typically occur with opioid use.

Nursing

There are no comments on this title.

to post a comment.
Manila Tytana Colleges Library | Metropolitan Park, Pres. Diosdado Macapagal Blvd., Pasay City, 1300
Tel.(+63-2) 859-0826 | E-mail library@mtc.edu.ph